These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
34. The clinical outcome and treatment in Behçet's disease with deep vein thrombosis. Akdağ Köse A; Kayabali M; Sarica R; Kaymaz R; Azizlerli G Adv Exp Med Biol; 2003; 528():495-501. PubMed ID: 12918752 [No Abstract] [Full Text] [Related]
35. Royal College of Physicians of Edinburgh. Consensus Conference on Medical Management of Stroke. 26 & 27 May 1998. Scott Med J; 1998 Aug; 43(4):123-4. PubMed ID: 9757506 [No Abstract] [Full Text] [Related]
36. Towards evidence-based treatment of thrombotic antiphospholipid syndrome. Derksen RH; de Groot PG Lupus; 2010 Apr; 19(4):470-4. PubMed ID: 20353990 [TBL] [Abstract][Full Text] [Related]
37. A meta-analysis of transcatheter closure of patent foramen ovale versus medical therapy for prevention of recurrent thromboembolic events in patients with cryptogenic cerebrovascular events. Pineda AM; Nascimento FO; Yang SC; Kirtane AJ; Sommer RJ; Beohar N Catheter Cardiovasc Interv; 2013 Nov; 82(6):968-75. PubMed ID: 23832613 [TBL] [Abstract][Full Text] [Related]
38. [Efficacy and safety of rituximab in the treatment of primary antiphospholipid syndrome: analysis of 24 cases from the bibliography review]. Pons I; Espinosa G; Cervera R Med Clin (Barc); 2015 Feb; 144(3):97-104. PubMed ID: 24698717 [TBL] [Abstract][Full Text] [Related]
39. [Treatment of diffuse glomerulonephritis in adults with Schönlein-Henoch disease using a combination of anticoagulants, corticosteroids and immunosuppressants]. Belovezhdov N Vutr Boles; 1986; 25(2):21-5. PubMed ID: 3716373 [TBL] [Abstract][Full Text] [Related]
40. Use of anticoagulants or antiplatelet aggregating drugs in the prevention of ischemic stroke. Adams HP Adv Intern Med; 1995; 40():503-31. PubMed ID: 7747656 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]